Sonexa Therapeutics Raises $30M

San Diego-based Sonexa Therapeutics said last week that the firm has raised $30M in a Series A funding. The round came from Domain Associates, Scale Venture Partners, and Alta Partners, and also included AgeChem Venture Fund and MC Life Science Ventures. Sonexa is developing biopharmaceuticals focused on the treatment of Alzheimer's disease. The firm's compounds are based on technology licensed from a Japanese pharmaceutical company. According to Sonexa, the proceeds from the funding will go to fund the licensing and development of its products. Eckard Weber of Domain Associates has been appointed chairman and CEO of the firm. More information »